Results 191 to 200 of about 31,642 (216)
Acute intermittent porphyria and early hematin treatment
, 2014 Viroj Wiwanitkit
openalex +1 more source
Lepidoptera Lexicon: Metaphorical Descriptors in Dermatology. [PDF]
Indian Dermatol Online JSivasankari R +3 more
europepmc +1 more source
A New Generation of Porphyrias: A Case of Acute Intermittent Porphyria. [PDF]
CureusSousa M +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Pharmacology and Therapeutics, 2020
Givosiran is a small interfering ribonucleic acid agent that was recently approved in the United States for the treatment of acute hepatic porphyria (AHP).
Sagar Agarwal
exaly +2 more sources
Givosiran is a small interfering ribonucleic acid agent that was recently approved in the United States for the treatment of acute hepatic porphyria (AHP).
Sagar Agarwal
exaly +2 more sources
Systemic messenger RNA as an etiological treatment for acute intermittent porphyria
Nature Medicine, 2018Pedro Berraondo +2 more
exaly +2 more sources
Givosiran to treat acute porphyria.
Drugs of Today, 2021Porphyrias are a family of rare diseases chiefly due to inborn errors of heme biosynthesis. The porphyrias are generally characterized either by the main site of overproduction of heme precursors (hepatic or erythropoietic) or the main clinical ...
A. Honor, S. Rudnick, H. Bonkovsky
semanticscholar +1 more source
Givosiran - Running RNA Interference to Fight Porphyria Attacks.
New England Journal of Medicine, 2020The porphyrias are a group of rare and ultra-rare devastating disorders of heme biosynthesis. The majority of these disorders are inherited, and patients present with disabling symptoms that have a...
G. González-Aseguinolaza
semanticscholar +1 more source